Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 310-080-1 | CAS number: 102242-49-9 The complex residue resulting from the vacuum distillation of C6-24 fatty alcohols which is derived from hydrogenation of C6-24 fatty acids methyl esters. It consists predominantly of satd. fatty alcohols having carbon numbers greater than C18, dimerization products, and long chain esters having carbon numbers greater than C32 and boils at > 250°C (482°F) at 10 torr.
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
No study is available in which the toxicokinetic properties (distribution, metabolism, elimination) of the substance were specifically investigated. In fact, such a study is hardly feasible due to the complex UVCB-composition of the substance.
The expected toxicokinetic behaviour is derived from the physicochemical properties, the results from the available toxicological studies and the available literature following the information given in guidance document 7c.
The substance is a solid (at 20°C) with a water solubility of <0.05 mg/L (20°C) and a lipophilic character (log Pow >5.7). It has a very low vapour pressure of <0.014 P (20°C) and consequently a very low volatility. It is not surface active.
Oral and GI absorption:
Substance is not soluble in water and in GI fluids. It will not easily pass through aqueous pores or epithelial barriers. The substance or parts of the substance may be taken up by micellular solubilisation. The limited systemic toxicity data on representative constituents of the substance furthermore does not indicate absorption through the GI tract. This is supported by experimentally determined poor gastrointestinal absorption of the main constituent octadecan-1-ol.
Inhalative absorption:
The substance does not easily pass through aqueous pores or epithelial barriers. Absorption via the lung is therefore not assumed to occur to a significant extent.
Dermal absorption:
Due to the physico-chemical information, the substance can be assumed to be absorbed via the skin.
Distribution:
Because of the very low solubility, poor distribution can be assumed. Fatty alcohols may enter lipid biosynthesis, but fatty acids derived from fatty alcohols will be indistinguishable from the lipids derived from other sources.
Accumulative potential:
Based on the PC information the main site of accumulation is assumed to be the adipose tissue as well as skin. No accumulation in bone or in lung is predicted. There is only limited potential for retention or bioaccumulation for long chain alcohols, i.e. the parent alcohols and their biotransformation products.
Metabolism:
Linear or essentially linear hydrocarbon chains are readily oxidised metabolically. Long chained alcohols, which sum up to about 70%of the substance, are generally highly efficiently metabolised either by oxidation to the corresponding carboxylic acids, followed by a stepwise elimination of C2 units in the mitochondrial β-oxidation process. The end product acetyl CoA enters the citric cycle and is furthermore metabolised to CO2 and water. This process may be preceeded by a ω or ω-1 oxidation. Alternatively, they might be used in lipid biosynthesis. Consequently, there is limited potential for retention or bioaccumulation for the parent alcohols and their biotransformation products.
The wax ester components of the substance are assumed to be metabolised to alcohols and fatty acids, both of which are further metabolised as described above.
Reactivity:Available studies on genotoxicity were negative, i.e. there is no indication of a reactivity of the test substance or its metabolites under the test conditions.
Excretion:
The metabolic end products carbon dioxide and water are excreted via urine or exhaled.Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
